Patent · US Expired

Isolated cancer associated antigens NY-MEL 1 and NY-MEL 3, peptides based thereon, and their uses

US7132507B2 · kind B2 · utility

0Cited by

2References

4Claims

0Family size

Assignees

LUDWIG INSTITUTE FOR CANCER RESEARCH LTD · GB
Memorial Sloan Kettering Cancer Center · US
Cornell Research Foundation, Inc. · US

Inventors

Dirk Jager · New York, US
Elizabeth Stockert · New York, US
Matthew Scanlan · Princeton Junction, US
Ali Gure · New York, US
Elke Jager · Frankfurt am Main, DE
Alexander Knuth · Frankfurt am Main, DE
Lloyd J. Old · New York, US
Yao-Tseng Chen · New York, US

Key dates

Filing date	May 21, 2002
Grant date	Nov 7, 2006
Priority date	—
Expiry date	Dec 22, 2023

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to isolated, cancer associated antigens, nucleic acid molecules, and various uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.